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Summary
Yeast supplementation has been shown to increase feed intake and production in 
some studies with early lactation dairy cows, but the mechanisms underlying this effect 
remain unknown. The objective of this study was to assess the effects of supplementing 
a yeast product derived from Saccharomyces cerevisiae on production, feeding behavior, 
and immune function in cows during the transition to lactation. When fed for 3 weeks 
before calving through 6 weeks after calving, supplementation altered feeding behavior 
as well as responsiveness to vaccination and gut immunoglobulin secretion. Results sug-
gest that yeast products can modulate several aspects of immune function and promote 
the consumption of smaller, more frequent meals.
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Introduction
The 2 weeks after calving remain the most challenging window of time during the dairy 
production cycle, often accounting for more than 50% of total disease in the lactating 
herd. The health challenges at this time include both metabolic and infectious diseases, 
resulting in a complex problem, often without any obvious cause. Our current under-
standing of transition cows suggests that rapid weight loss caused by low feed intake as 
well as poor immune function during this time combine to lead to these health prob-
lems.
Relatively strong evidence indicates that dietary yeast culture can increase DMI in early 
lactation, and more recent evidence suggests that this can happen through alterations 
in meal patterns. Furthermore, many studies in model organisms and young ruminants 
have suggested that yeast products can alter numerous functions of the immune system. 
In light of the immunosuppression that occurs during the transition period, there is 
great interest in the use of a yeast product to enhance immune function during this 
time when mammary and uterine infections are such a challenge. Our objective was to 
determine whether supplementing a yeast product derived from Saccharomyces cerevisi-
ae altered production, feeding behavior, and measures of immune function in transition 
cows.
Experimental Procedures
Forty multiparous Holstein cows were blocked by expected calving date and randomly 
assigned within block to 1 of 4 treatments (10 cows per treatment) from 21 days before 
expected calving to 42 days postpartum. Rations were top-dressed with yeast culture 
plus enzymatically hydrolyzed yeast (YC-EHY; Celmanax, Vi-COR, Mason City, IA) 
at the rate of 0, 30, 60, or 90 g/day throughout the experiment. The basal diets fed pre-
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partum and postpartum are detailed in Table 1. Dry matter and water intake, feeding 
behavior, and milk production were monitored daily throughout the study.
To evaluate humoral immune function, cows were challenged (subcutaneous injection) 
with 1 mg of ovalbumin (OVA; Sigma-Aldrich, St. Louis, MO) diluted in vaccine adju-
vant (VET-SAP, Desert King International, San Diego, CA; 0.5 mg of adjuvant dis-
solved in 1 mL of saline) on days -21, -7, and 14. Blood samples were collected on days 
-21, 14, and 21 relative to calving from the coccygeal vessels 1 hour prior to feeding for 
determination of antibody titer against OVA. To evaluate mucosal immune function, 
fecal samples were collected on days 7 and 21 of lactation for analysis of immunoglobu-
lin A (IgA) concentration.
To evaluate the efficiency of net energy utilization for milk production, energy supplied 
by the diet and body condition mobilization were estimated. Energy utilization efficien-
cy was then quantified as milk energy output / (diet energy supply + energy from body 
condition mobilization).
One cow in the 0 g/day treatment group was removed from the study on day 30 post-
partum due to difficulty standing up in the tie-stall. Data obtained from this cow prior 
to removal were included in all analyses. Feeding behavior variables were calculated 
from logged data that included the start and end weights as well as start and end times 
of meals, and meals were combined if the intermeal interval was less than 12 minutes. 
Data were analyzed using mixed models with repeated measures over time. Models in-
cluded the fixed effects of treatment, time, and their interaction, and the random effect 
of cow. Contrast statements were used to assess the overall effect of YC-EHY (control 
vs. all YC-EHY treatments) as well as the linear and quadratic effects of dose. Signifi-
cance was declared at P ≤ 0.05 and tendencies at 0.05 < P ≤ 0.10.
Results
Pre- and postpartum DMI and water intake did not differ (P > 0.10) among treatments 
(Table 2). Quadratic dose effects (P < 0.05) were detected for prepartum feeding behav-
ior, reflecting decreased meal size and increased meal frequency for cows that received 
30 and 60 g/day of YC-EHY. Postpartum feeding behavior and milk yield were unaf-
fected (P > 0.10) by treatments, but tendencies for increased (P ≤ 0.10) percentages of 
milk fat, protein, and lactose were detected for cows receiving YC-EHY (Table 3). Fur-
thermore, YC-EHY tended to increase the proportion of total energy supply secreted in 
milk nutrients (P ≤ 0.10; Table 3).
Increasing YC-EHY dose linearly increased (P < 0.01) plasma anti-ovalbumin IgG lev-
els following 3 ovalbumin challenges (Figure 1A), suggesting that treatments enhanced 
humoral immunity. Increasing YC-EHY dose also quadratically increased fecal IgA 
concentrations in early lactation (P = 0.03; Figure 1B), suggesting that 30 and 60 g/day 
doses enhanced mucosal immunity.
Discussion
These results provide some intriguing evidence that YC-EHY shifts meal patterns 
and results in cows eating smaller, more frequent meals. Although this was found to 
be significant only prepartum, numerical patterns during the postpartum period were 
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similar. Smaller, more frequent meals may be beneficial from the standpoint of main-
taining stable ruminal conditions, because very large meals provide a lot of fermentable 
substrate and can result in decreased ruminal pH, at least for a short period of time. We 
found no evidence, however, that YC-EHY increases DMI in the critical first 6 weeks 
after parturition. 
By accounting for energy derived from release of stored tissue (i.e., body fat), we found 
that YC-EHY tended to improve efficiency of energy utilization for milk production. 
Substantial evidence in past studies indicates that yeast products can improve diet 
digestibility in ruminants. Although we did not directly measure this, the tendency for 
increased energy efficiency with YC-EHY in our study is consistent with an increase in 
diet digestibility.
We found that YC-EHY increased antibody production following vaccination against 
OVA and, at intermediate doses, increased gastrointestinal IgA release. Humoral im-
munity (antibody-based protection) is thought to be suppressed during the transition 
to lactation, so the ability of a feed additive to enhance this capacity is encouraging. 
Secretion of IgA by mucosal immune cells lining the gut is one key mechanism that 
helps prevent attachment of gut pathogens to the epithelium, thereby minimizing gas-
trointestinal disease. These findings are interesting, but whether or not a feed additive 
limits the risk of infection or speeds recovery from infection must be tested in disease 
challenge studies or large-scale studies capable of assessing health risks.
Conclusions
Feeding a yeast culture product with enzymatically hydrolyzed yeast did not affect milk 
production or DMI during the transition to lactation but modulated feeding behavior 
and several aspects of immunity. In the current study, a 60 g/day dose of YC-EHY 
resulted in favorable changes in feeding behavior, mucosal and humoral immunity, and 
supported the numerically greatest energy efficiency and milk yield postpartum. Fu-
ture studies with larger numbers of animals may provide more insight into production 
implications of these biological responses.
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Table 1. Ingredient and nutrient composition of diets
Item Prepartum Postpartum
Ingredient, % of DM
Corn silage 29.5 15.9
Wet corn gluten feed 21.3 34.3
Alfalfa hay - 14.2
Wheat straw 10.9 3.3
Prairie hay 16.8 -
Cottonseed - 5.0
Ground corn 3.4 11.2
Dry-rolled sorghum grain 3.4 6.4
Mechanically extracted soybean meal 12.3 4.8
Molasses 1.2 1.2
Ca salts of long-chain fatty acids - 0.8
Micronutrient premix 1.3 2.9
Nutrient, % of DM
DM, % as-fed 45.4 51.1
CP 13.0 17.7
Starch 21.1 20.2
ADF 24.4 16.9
NDF 42.5 31.0
NFC 33.8 41.1
Ether extract 3.3 4.2
Ash 6.0 8.3
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Table 2. Feed and water intake and feeding behavior responses to yeast culture-enzymatically hydrolyzed yeast 
(YC-EHY) supplementation during the experimental period
Treatment (YC-EHY dose/day) P-value
Item 0 g 30 g 60 g 90 g SEM
YC-EHY 
vs. Con
Linear 
dose
Quadratic 
dose
Prepartum measures
DMI, kg/day 12.1 11.9 12.6 12.1 0.51 0.86 0.77 0.76
Water intake, L/day 49.0 48.3 49.0 51.3 2.38 0.84 0.48 0.53
Meal frequency, per day 10.1 11.4 11.2 10.0 0.45 0.12 0.80 0.01
Intermeal interval, hours 2.08 1.87 1.94 2.08 0.08 0.18 0.86 0.02
Meal size, kg DM 1.23 1.06 1.16 1.24 0.06 0.27 0.68 0.04
Meal length, minutes 20.6 17.7 17.3 21.1 1.58 0.31 0.87 0.04
Postpartum measures
DMI, kg/day 21.8 19.7 21.5 22.8 1.13 0.73 0.34 0.14
Water intake, L/day 105.6 96.1 105.6 105.2 5.15 0.59 0.72 0.40
Meal frequency, per day 12.8 13.1 13.5 12.2 0.62 0.85 0.62 0.19
Intermeal interval, hours 1.50 1.50 1.42 1.60 0.08 0.90 0.53 0.29
Meal size, kg DM 1.81 1.69 1.76 1.93 0.10 0.87 0.34 0.14
Meal length, minutes 26.4 25.0 25.3 26.7 1.11 0.56 0.80 0.19
Table 3. Milk production and composition responses to yeast culture-enzymatically hydrolyzed yeast (YC-EHY) 
supplementation during the experimental period
Treatment (YC-EHY dose/day) P-value
Item 0 g 30 g 60 g 90 g SEM
YC-EHY 
vs. Con
Linear 
dose
Quadratic 
dose
Milk yield, kg/day 45.3 42.6 47.8 46.7 2.53 0.90 0.39 0.72
Milk fat, % 4.11 4.38 4.33 4.17 0.13 0.20 0.80 0.09
Milk protein, % 2.99 2.89 3.04 3.12 0.07 0.76 0.08 0.17
Milk lactose, % 4.77 4.74 4.84 4.85 0.05 0.45 0.10 0.67
Milk urea nitrogen, mg/dL 13.3 14.1 13.4 13.9 0.63 0.44 0.65 0.81
Fat yield, kg/day 1.81 1.82 2.02 1.90 0.09 0.32 0.24 0.46
Protein yield, kg/day 1.34 1.21 1.42 1.42 0.08 0.86 0.17 0.42
Lactose yield, kg/day 2.16 2.03 2.32 2.26 0.13 0.78 0.30 0.79
Energy utilization efficiency1, % 74.9 79.5 82.6 81.5 3.1 0.08 0.11 0.36
1 Milk energy output divided by energy provided by feed and BCS mobilization.
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Figure 1. Antibody responses to yeast culture with enzymatically hydrolyzed yeast (YC-
EHY) supplemented to dairy cows at 0, 30, 60, or 90 g/day from 21 days before expected 
parturition to 42 days after parturition. (A) Plasma concentrations of anti-ovalbumin IgG 
collected on days -21, -14, and 21 relative to calving. Cows were challenged on days -21,  
-7, and 14 with ovalbumin. There was a tendency for linear dose effect (P = 0.06) and a  
day effect (P < 0.01) but no yeast product vs. control (P = 0.41) or quadratic dose  
(P = 0.50) effects. A treatment × day (P < 0.01) effect was detected, reflecting that yeast 
product linearly increased (P < 0.01) anti-ovalbumin IgG on day 21. (B) Concentrations of 
IgA in fecal samples collected on days 7 and 21 relative to calving. There was a significant 
quadratic dose effect (P = 0.03), but no yeast product vs. control (P = 0.16), linear dose  
(P = 0.73), day (P = 0.61), or treatment × day (P = 0.42) effects.
